Month: September 2024

Julia Haart and Liev Schreiber Raised Vital Funds for Ukrainian Children

East Hampton, NY – A special fundraising event, organized by Mriya Gallery over Labor Day weekend raised $31,380 to support children affected by the war in Ukraine. The funds will benefit BlueCheck Ukraine, an organization co-founded by Liev Schreiber and supported by former Doctors Without Borders leaders, filmmakers, and social entrepreneurs.

Guests enjoyed a diverse collection, including Ukrainian art pieces from Mriya Gallery and Rukh art Hub, private works by Scott Baxter,who generously provided his beautiful estate for the event –  masterpieces by renowned artists such as Warhol, Rodin, and Dali. The event not only celebrated Ukrainian culture but also underscored the urgent humanitarian needs on the ground.

Attendees were moved by a powerful speech from Julia Haart, fashion designer and “My Unorthodox Life” Netflix star who shared her personal experiences of delivering ambulances to Bakhmut and emphasized the importance of supporting Ukraine’s fight for freedom. “There are moments in life where you realize that you’re in a place for a purpose that is so much greater than yourself,” Haart remarked. “The fight that is happening in Ukraine today is a battle for freedom, and it is our duty to stand with them.” Haart also made headlines by purchasing the first painting of the evening—a work titled In Blossom #6 by Dasha S. Kandinsky, a contemporary artist born in Kyiv and now based in Switzerland, and a descendant of the Kandinsky dynasty.

Liev Schreiber, co-founder of BlueCheck Ukraine, addressed the guests with a message of gratitude, acknowledging the critical support provided by the event. “Although I couldn’t be there in person, your presence and contributions mean the world to us,” Schreiber said. “As Ukraine defends itself against Russia’s brutal and multifaceted attack, it is more essential than ever to celebrate and reinforce Ukrainian culture and identity. The best defense against any attempt at genocide is a broad embrace of the humanity and culture at the heart of it. What they are fighting for is simply the right to exist—to raise their children and their children’s children as Ukrainians”.

A moment of silence was observed for all children in Ukraine, adding a poignant note to the evening.

The event was further enriched by performances from the Fima Chupakhin Jazz Band and DJ Anastasia Bondarenko, along with a curated dinner by chef Dima Martseniuk, making it a memorable and impactful occasion.

As Ukraine continues to face unprecedented aggression, events like this play a crucial role in celebrating and reinforcing Ukrainian culture while providing essential support. The funds raised will help ensure that children and their families receive the urgent assistance they need during these challenging times.

Please donate: https://www.bluecheck.in/hamptons-art-hope-gala.

https://www.rukharthub.com/

Media Contact
Company Name: Mriya Gallery, currated by Rukh Art Hub
Email: Send Email
Phone: 1 (424) 303-2455
Address:101 Reade St
City: New York
State: NY 10013
Country: United States
Website: https://mriya.nyc/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Julia Haart and Liev Schreiber Raised Vital Funds for Ukrainian Children

Kodiak Fence Company Opens New Location in Dallas, Texas, Offering High-Quality Fencing Solutions

Dallas, TX – Sep 6, 2024 – Kodiak Fence Company, a leading fence contractor recognized for its speed, reliability, and customer-focused services, is excited to announce the launch of its new location in Dallas, Texas. With over 10 years of experience in the fence installation industry, Kodiak brings top-tier residential and commercial fencing services to the Dallas-Fort Worth Metroplex.

Located at 17480 Dallas Pkwy #111, Dallas, TX 75287, the new office will serve as the base for providing a wide range of fence solutions, including wood, chain-link, and custom fence installations. Kodiak Fence Company is committed to meeting the growing demand for durable, secure, and aesthetically appealing fences in Dallas and surrounding areas.

Delivering Quality and Trust

Kodiak Fence Company has built its reputation on delivering quality craftsmanship and unmatched customer service. The company’s highly skilled team ensures each project is completed efficiently and to the highest standards. Whether clients are looking for a classic wood fence, a secure chain-link option, or a custom design, Kodiak provides personalized solutions tailored to meet specific property needs.

“Our mission is simple: provide our customers with high-quality fences that add value, security, and beauty to their properties,” said Alberto M., CEO of Kodiak Fence Company. “We are excited to bring our expertise and customer-first approach to the Dallas area, and we look forward to building long-lasting relationships with homeowners and businesses here.”

Comprehensive Fence Services

Kodiak Fence Company offers a variety of fencing options for both residential and commercial properties:

•  Wood Fences: Available in a wide range of styles, from privacy fences to picket designs. Kodiak ensures high-quality materials and expert craftsmanship, delivering fences that are both durable and visually appealing.

•  Chain-Link Fences: Ideal for both security and functionality, chain-link fences are a durable option for many types of properties. Kodiak’s installations are designed for long-lasting performance and custom-fitted to the property’s needs.

•  Custom Fences: For clients looking for something unique, Kodiak’s team offers custom fence designs that enhance the beauty and security of any space.

The company also offers free consultations and quotes to ensure every project aligns with the customer’s vision and budget. Kodiak is dedicated to completing projects on time while maintaining the highest quality standards.

Supporting Local Communities

Kodiak Fence Company takes pride in supporting the local Dallas economy by employing local professionals and sourcing materials from reputable suppliers in Texas. The company is also a member of the American Fence Association and is BBB-accredited, which reflects their dedication to excellence and integrity.

“As we expand into Dallas, we remain committed to delivering high-quality services while supporting the community,” said Alberto M. “We want to be the trusted fencing partner for homeowners and businesses alike.”

About Kodiak Fence Company

Founded by professionals with over 10 years of experience, Kodiak Fence Company is known for speed, reliability, and exceptional workmanship. Specializing in wood and chain-link fencing for residential and commercial properties, the company provides top-tier fencing solutions tailored to clients’ needs.

Media Contact
Company Name: Kodiak Fence Company
Contact Person: Media Relations
Email: Send Email
City: Dallas
State: TX 75287
Country: United States
Website: https://kodiakfencecompany.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Kodiak Fence Company Opens New Location in Dallas, Texas, Offering High-Quality Fencing Solutions

Stone Flooring Market Size, Opportunities, Top Manufacturers, Growth, Trends, Regional Graph, Key Segments, and Forecast to 2029

“Browse 211 market data Tables and 43 Figures spread through 202 Pages and in-depth TOC on “Stone Flooring Market””
The Stone Flooring Market is expanding due to rising demand for durable and aesthetic flooring solutions in residential and commercial spaces. Growth is fueled by trends in home renovation and construction, with strong activity in North America and Asia-Pacific.

The global stone flooring market size is projected to grow from USD 14.7 billion in 2024 to USD 19.9 billion by 2029, at a CAGR of 6.3% during the forecast period. The stone flooring market is thriving due to a combination of economic, technological, and environmental factors. Economic growth and rising incomes in nations such as China and India are driving up construction, and increasing demand for stone floors. Advances in stone cutting and sealing technology have simplified the installation and maintenance of stone flooring. People admire stone flooring because it comes in a variety of colors, textures, and patterns, making it an ideal choice for homes, companies, and luxury hotels. Environmental concerns are also increasing demand for eco-friendly stone products sourced from renewable resources. All of these characteristics contribute to the growing popularity and widespread use of stone flooring.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43652813  

A few of the major players in the stone flooring market are, Mohawk Industries, Inc. (US), Shaw Industries Group, Inc. (US), Stone Source LLC (US), Polycor Inc. (US), and Emser Tile (US). These players have implemented various growth strategies, such as acquisitions, partnerships, and expansions to enhance their market shares and boost their product portfolios.

Mohawk Industries, Inc. is a leading global flooring manufacturer. Its vertically integrated manufacturing and distribution processes give it a competitive edge in producing a wide range of flooring options, including carpet, rugs, ceramic tiles, laminate, wood, stone, luxury vinyl tile (LVT), and sheet vinyl flooring. The company has fully integrated operations in North America, Europe, Latin America, and Australasia. It manufactures products in 19 countries on five continents and sells them in nearly 170 nations. The company operates through three reporting segments: Global Ceramic, Flooring North America (Flooring NA), and Flooring Rest of the World (Flooring ROW). Global Ceramic designs, manufactures, sources, distributes, and markets various ceramic, porcelain, and natural stone tile products. The company’s brands, among the most recognized in the industry, include American Olean, Daltile, Decortiles, Durkan, Eliane, Elizabeth, Feltex, Godfrey Hirst, IVC Commercial, IVC Home, Karastan, Kerama Marazzi, Marazzi, Moduleo, Mohawk, Pergo, Quick-Step, Unilin, and Vitromex. The Daltile brand offers stone flooring products including granite, limestone, marble, slate, and travertine tiles. Daltile operates as a subsidiary of Mohawk Industries.

Shaw Industries Group, Inc. is a wholly-owned subsidiary of Berkshire Hathaway, Inc. The company manufactures and supplies a wide range of products, including carpet, resilient flooring, hardwood, tile and stone, synthetic turf, and other specialty items. It caters to both residential and commercial markets globally through brands such as Anderson Tuftex, COREtec, Patcraft, Philadelphia Commercial, Shaw Contract, Shaw Floors, Shaw Sports Turf, Shawgrass, Southwest Greens, and Watershed Geo. The company’s stone flooring portfolio includes marble, natural stones, and other stone types. It has 51 distribution facilities and sales offices in the US, Australia, Belgium, Brazil, Canada, Chile, China, France, the Netherlands India, Mexico, Singapore, UAE, Vietnam, and the UK.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43652813 

Stone Source LLC is a designer and supplier of high-quality natural stone and tile products for both commercial and residential projects. The design-focused company provides a wide selection of luxurious materials for architecture and interior design, with natural stone being particularly popular. Its sought-after options include marble, limestone, quartzite, travertine, and basalt. The company also offers an expertly curated collection featuring granite, onyx, and slate. The US-based company has showrooms in Atlanta, Chicago, Carlstadt, Dallas, East Hampton, Houston, Nashville, New York, and Washington.

Polycor Inc. is a leading global quarrying company for natural stone. The company offers granite, marble, limestone, and soapstone products for both commercial and residential applications such as walls, urban landscaping, commercial flooring, kitchens and bathrooms, and monuments. Its brands include Swenson Granite Company LLC, Vetrazzo, LLC, and Rock of Ages. The company operates more than 60 quarries and more than 20 manufacturing plants across North America and Europe.

Emser Tile designs, markets, and produces top-quality tile and natural stone. It offers a wide range of products, including porcelain, ceramic, metal, glass, quarry, decorative accents, mosaics, cut-to-size stone, and custom-manufactured items. The company’s products are suitable for both residential and commercial projects. Emser Tile has manufacuring facilities across the US, and advanced distribution centers providing over 3 million sq. ft. of storage space, allowing it to ensure that products are readily available and easily accessible. With more than 78 locations and partnerships with factories in over 20 countries, Emser has the capability to handle local or international projects of any size.

The companies have initiated the following developments:

  • In October 2023, Emser Tile, a leading designer and manufacturer of top-quality tile and natural stone products, unveiled Emser Tech, a cutting-edge product testing facility. This state-of-the-art facility is fully equipped to conduct all industry-standard tests efficiently. With this new facility, Emser can ensure the validation of testing, data analysis, and quality control measures. This strategic move empowers the company to not only meet but surpass industry standards.
  • In September 2023, Polycor Inc. acquired ROCAMAT, a prominent French natural stone producer and a key player in the global building stone industry.
  • In February 2023, Polycor Inc. acquired Ebel Quarries, a limestone quarrying and fabrication company based in Wiarton, Ontario. The acquisition enables Polycor to enhance its presence in Ontario, meet the rising demand for natural stone, and diversify its extensive product line by incorporating a new subsidiary into its extraction and finishing network.
  • In May 2022, Birch Hill Equity Partners and Investissement Québec acquired Polycor Inc. in partnership with the company’s management team from TorQuest Partners and its co-investors, Wynnchurch Capital and PNC Mezzanine Capital. Polycor finalized the transaction on April 29, 2022. This deal will support Polycor’s ongoing growth in Québec and its global operations.
  • In April 2022, Paramount Global Surfaces, a portfolio company of Platinum Equity, acquired Stone Source from a group of investors headed by Founders Equity. Partnering with PGS will give Stone Source the advantage of increased scale and allow it to offer customers a more extensive range of products.
  • In February 2022, Diverzify, a commercial flooring installation, and interior services company, announced a merger with Shaw Industries Group Inc. This will help Shaw Industries Group, Inc. to strengthen its market position.
  • In August 2020, Shaw Industries Group, Inc. (Shaw) invested approximately USD 20 million in the expansion of its resilient manufacturing capabilities in Ringgold, Georgia.
  • In November 2019, Emser Tile inaugurated its 76th branch in North America. Located 18 miles northwest of Philadelphia, this new showroom will cater to central and eastern Pennsylvania, and Southern New Jersey, as well as parts of New York and Delaware. Positioned strategically in the Philadelphia market, which shows promise for both remodeling and new construction projects, the new location offers convenience to Emser Tile’s growing base of customers in the Mid-Atlantic region.
  • In July 2019, Emser Tile opened its 75th branch in North America. The second branch in Atlanta, Georgia, it reflects the company’s ongoing dedication to the region. The addition enhances accessibility to Emser Tile’s diverse range of tile and natural stone products for both residential and commercial projects, particularly benefiting customers conducting business on the west side of Atlanta.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=43652813 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/stone-flooring-market-43652813.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stone Flooring Market Size, Opportunities, Top Manufacturers, Growth, Trends, Regional Graph, Key Segments, and Forecast to 2029

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Experiences Significant Growth

“Live Biotherapeutic Products And Microbiome Contract Manufacturing Market”
Live Biotherapeutic Products And Microbiome Contract Manufacturing Market is worth US$ 355.9 Million in 2021 and is predicted to reach US$ 2,608.0 Million in 2030, with a promising CAGR of 25.2% between 2024 and 2031.

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “ Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market (By Product Manufactured (APIs, FDFs), Type of Formulation (Solid Formulations, Oral Liquids, Injectables, Others), Scale of Operation (Preclinical Scale Operations, Clinical Scale Operations, Commercial Scale Operations), Company Size, (Small-sized Companies, Mid-sized Companies, Large Companies))- Market Outlook and Industry Analysis 2030″

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/1152

According to company’s newest research, the Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market is worth US$ 355.9 Million in 2021 and is predicted to reach US$ 2,608.0 Million in 2030, with a promising CAGR of 25.2%  between 2024 and 2031.

The collection of many bacteria that live in and in the human body is known as the human microbiome. For instance, the skin, gut, mouth, and vagina all have microbiomes. Using LBPs and microbiome therapeutics has created new opportunities and perspectives directly aligned with sustainable development goals. Microbiome therapy developers are actively outsourcing some manufacturing activities while enhancing their in-house skills because of the complicated manufacturing procedures, the need for improved GMP production facilities, and the scarcity of innate expertise. In contrast to vaccines, live biotherapeutic medicines contain alive organisms, such as bacteria. These products can be utilized to prevent, treat, or cure a human disease or condition. Specific microbiome abnormalities, known as dysbiosis, have been associated with health problems, and this is probably due to the loss of microbial metabolites, signalling molecules, or host process regulators. Inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), type 2 diabetes, obesity, and metabolic syndrome have been linked to dysbiosis. LBPs exert their effect by directly interacting with the native microbiota or changing the connection between the host and the microbiota, leading to an indirect biological impact on the patient.

As a result of the progress made in the clinical pipeline by a number of potentially useful microbiome-based live biotherapeutic products, it is anticipated that this forthcoming therapeutic segment will become one of the markets within the pharmaceutical industry that will experience the highest rate of growth over the next few years. Most clinical treatments are in the preclinical stage; a few are in clinical development, and about 15 are in phase II/III trials. Commercializing these items in the upcoming years is anticipated to create significant market expansion potential throughout the expected timeframe.

However, growth in this sector could be stunted if the pioneers don’t have adequate production capabilities. Market expansion is being hampered by many challenges, including a deficiency in important industry standards connected to the production of live biotherapeutics, issues with batch-to-batch stability, a lack of infrastructure, and unknowns surrounding product approval and regulatory scrutiny. However, a rise in contract manufacturing agreements between companies is expected to open up massive new avenues for the industry’s expansion worldwide. Additional challenges modern inventors share are related to assuring compliance with good manufacturing standards (GMP) and production capacity.

Rapid expansion is predicted for North America in the following years due to high demand and the substantial effects of COVID-19 (2024-2031 ). Product development and research on living biotherapeutic components are receiving massive financing from companies.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

The key players in this market include Quay Pharmaceuticals, Cobra Biologics Limited, Cerbios-Pharma SA, List Biological Labs, Inc., Arranta Bio, BacThera, Luina Bio Pty Ltd, 4D pharma plc, Paras Biopharmaceuticals Finland Oy, Capsugel, Deerland Probiotics & Enzymes, Paragon Bioservices, UAS Labs, Biose, Cobra Biologics, Cerbios, Inpac Probiotics, BJP Laboratories, S-Biomedic, Meteoric Biopharmaceuticals, BiomX, Universal Stabilization Technologies, Assembly Biosciences, Wacker Biotech,  and Chung Mei Pharmaceutical. The live biotherapeutic products and microbiome contract manufacturing market have several players across the globe. The growing research and development activities and partnerships among the key players operating in the market to seek different companies’ platforms are expected to boost the market in the coming years significantly.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/1152

Key Developments In The Market

  • In July 2022, Quay Pharma and SGS worked together to create a novel oral treatment for inflammatory bowel disease. Millions of people with Crohn’s disease and ulcerative colitis may make a difference in their lives because of this new oral medication. For pharmaceutical and biotechnology firms worldwide, SGS’s Quay Pharma offers a complete outsourcing service for formulation and analytical development, followed by clinical trials and commercial manufacture.
  • In June 2020, To broaden the microbial platform and increase the flexibility of probiotic manufacturing, Chr. Hansen acquired UAS Laboratories LLC. The acquisition does not affect the company’s ability to pay an ordinary dividend of between 40% and 60% of net profit and is entirely consistent with Chr. Hansen’s capital allocation policies. Low-interest bridging financing from core banks will be used to pay the acquisition price.
  • In Apr 2019, Catalent, Inc., Paragon Bioservices, Inc., and Catalent Inc. announced that they had signed a legally binding agreement under which Catalent would pay $1.2 billion to purchase Paragon. The deal will provide Catalent’s stockholders with desirable value, and Paragon will represent a modest portion of Catalent’s business in the short term. Still, over time, the acquisition will change the company’s business profile and significantly speed up sales and EBITDA growth.

Market Segmentation

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Product Manufactured, 2024-2031  (Value US$ Mn)

  • APIs
  • FDFs

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Type of Formulation, 2024-2031  (Value US$ Mn)

  • Solid Formulations
  • Oral Liquids
  • Injectables
  • Others

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Scale of Operation, 2024-2031  (Value US$ Mn)

  • Preclinical Scale Operations
  • Clinical Scale Operations
  • Commercial Scale Operations

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Company Size, 2024-2031  (Value US$ Mn)

  • Small-sized Companies
  • Mid-sized Companies
  • Large Companies

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Region, 2024-2031  (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Country, 2024-2031  (Value US$ Mn)

  • U.S.
  • Canada

Europe Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Country, 2024-2031  (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Country, 2024-2031  (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Country, 2024-2031  (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Live Biotherapeutic Products And Microbiome Contract Manufacturing Market, by Country, 2024-2031  (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for the global Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market
  • To receive an industry overview and future trends of the Live Biotherapeutic Products And Microbiome Contract Manufacturing Market
  • To analyze the Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market drivers and challenges
  • To get information on the Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market size (Value US$ Mn) forecast to 2030
  • Significant investments, mergers & acquisitions in the Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market industry

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1152                                                                                                                                        

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Live Biotherapeutic Products and Microbiome Contract Manufacturing Market Experiences Significant Growth

iPSCs Manufacturing Services Market: Opportunities and Growth Drivers Revealed in New Report

“iPSCs Manufacturing Services Market”
iPSCs Manufacturing Services Market is worth US$ 1009.00 Million in 2021 and is predicted to reach US$ 2.61 Billion in 2030, with a promising CAGR of 11.5% between 2024 and 2031.

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “Global iPSCs Manufacturing Services Market  (By Application (Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking, Emerging Applications), End-User(Pharmaceutical & Biotechnology Companies, Academic institutes, Research Laboratories & CROs, Hospitals & Surgical Centres, Cell & Tissue Banks, Other End Users))- Market Outlook and Industry Analysis 2030”

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/1223

According to company’s newest research, the Global iPSCs Manufacturing Services Market  is worth US$ 1009.00 Million in 2021 and is predicted to reach US$ 2.61 Billion in 2030, with a promising CAGR of 11.5% between 2024 and 2031.

iPSCs, or induced pluripotent stem cells, are recognized as attractive and promising cell sources for various applications, including drug discovery and regenerative medicine. Since iPSCs are artificially created in culture from somatic cells using the ectopic co-expression of specific pluripotency factors, they do not naturally exist. These cells can distinguish into any of the 220 or more different types of human cells and are pluripotent, with the capacity for self-renewal. iPSCs are widely used in the efficacy and safety testing phases of the drug development process. Hepatocytes, cardiomyocytes, islet cells, vascular endothelial cells, and neurons are examples of iPSC-derived products that are now being examined to understand the causes of human-specific adverse events and toxicity screening during drug development. The services of iPSC manufacturing service providers include differentiation and reprogramming of iPSCs, characterizing, manipulating, and testing iPSC banks for release, as well as cryopreservation and bank storage. Additionally, they offer process development, manufacturing, and the development of analytical methods for iPSC therapies.

The automated iPSC production process is anticipated to have the highest CAGR in the upcoming years. The demand for automation systems is rising as a result of the growing need for minimally variable, large-scale, reproducible stem cells and differentiated progeny generation. Several nations have launched iPSC line collection projects to facilitate research on various disorders, such as diabetes, cardiovascular disease, and neurodegenerative diseases. More and more investments by organizations, strategic funding from the government, collaborations, and acquisitions will fuel the Market.

However, the creation of iPSCs may soon be hampered by the high cost of treatments and the lack of clarity regarding differentiated tissues. Additionally, procedures and methods for mass production are always being developed, which may act as a barrier to growth during the period covered by the prediction. There are various challenges that are preventing iPSC manufacturing service providers from expanding their businesses, such as a lack of automated production tools and the difficulty of modifying iPSC genes.

With its rapid pace of research into neuropathies, heart disorders, and the manufacture of tailored medicines, North America is predicted to lead the manufacturing services market in the forecast period, followed by Europe. The expansion will also be due to the substantial investments made to date to advance iPSC manufacturing.

Significant market key players are Lonza Group AG, I Peace Inc., Axol Bioscience Ltd., FUJIFILM Cellular Dynamics, Inc., RoslinCT, Takara Bio Inc,  Ncardia, Cynata Therapeutics Limited, Evotec SE, Celogics Inc, Catalent, Inc, CCRM, Applied StemCell Inc. (ASC), Thermo Fisher Scientific, Inc, Other Prominent Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Key developments in the Market

  • In Apr 2022, Ncardia has started a new business called CellisticTM to focus its expertise in induced pluripotent stem cells (iPSC) on the development and production of cell therapies. This strategy builds on Ncardia’s existing drug discovery solutions business and uses the company’s deep expertise in iPSC differentiation and expansion to focus resources and skills on meeting the growing demand for iPSC cell therapy solutions, such as the development of strong manufacturing platforms that are tailored to each cell type.
  • In Sept 2021, Fujifilm and Cynata formed a strategic agreement under which Fujifilm will offer commercial and clinical manufacturing services for and supply, Cynata’s CymerusTM therapeutic mesenchymal stem cell (MSC) products.
  • In Aug 2021, Catalent bought RheinCell Therapeutics. They planned to speed up access to high-quality iPSC banks by offering integrated solutions for everything from making plasmid DNA to supplying clinical trials.
  • In May 2021, An alliance for research and development between BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics was launched to develop cell treatments for ocular illnesses. The firms will pool their resources to find and create commercial iPS cell therapeutics for eye ailments.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/1223

Market Segmentation:

Global iPSCs Manufacturing Services Market, by By Applications, 2024-2031  (Value US$ Mn)

  • Research Products
  • Drug Development & Discovery
  • Cellular Therapy
  • Toxicology Screening
  • Personalized Medicine
  • Disease Modelling
  • Stem Cell Banking
  • Emerging Applications

Global iPSCs Manufacturing Services Market, by End-User, 2024-2031  (Value US$ Mn)

  • Pharmaceutical & Biotechnology Companies
  • Academic institutes, Research Laboratories & CROs
  • Hospitals & Surgical Centres
  • Cell & Tissue Banks
  • Other End Users

Global iPSCs Manufacturing Services Market, by Region, 2024-2031  (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America IPSCs Manufacturing Services Market, by Country, 2024-2031  (Value US$ Mn)

  • U.S.
  • Canada

Europe IPSCs Manufacturing Services Market, by Country, 2024-2031  (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific IPSCs Manufacturing Services Market, by Country, 2024-2031  (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America IPSCs Manufacturing Services Market, by Country, 2024-2031  (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa IPSCs Manufacturing Services Market, by Country, 2024-2031  (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for the global IPSCs Manufacturing Services Market
  • To receive an industry overview and future trends of the IPSCs Manufacturing Services Market
  • To analyze IPSCs Manufacturing Services Market drivers and challenges
  • To get information on the IPSCs Manufacturing Services Market size (Value US$ Mn) forecast to 2030
  • Significant investments, mergers & acquisitions in the IPSCs Manufacturing Services Market industry

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1223

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: iPSCs Manufacturing Services Market: Opportunities and Growth Drivers Revealed in New Report

International Blues Hall of Fame Legendary Blues Artist Stevie Hawkins Takes Home Two Blues Music Awards

“”I am incredibly grateful to receive these awards,” said Hawkins. “The blues is a powerful form of expression, and to be recognized as the Best Blues Artist and Best Blues Songwriter is truly an honor. I share this moment with my family, fans, and everyone who has supported my music journey.””
Blues Hall of Fame Legendary Blues Artist Stevie Hawkins’ extraordinary talent is exemplified by his dual wins of prestigious blues music awards in Hollywood.

Stevie Hawkins, a renowned blues artist, was recently honored with two prestigious awards at the 12th Annual Indie Music Channel Awards in Hollywood, California. Hawkins received the titles of Best Blues Artist and Best Blues Songwriter for his soul-stirring single “You Left Me With A Heartquake,” in recognition of his outstanding contributions to the blues genre.

Hawkins has been named Best Blues Artist for the third consecutive year, a testament to his remarkable achievements in the genre. Over the past several years, he has accumulated an impressive ten prestigious blues music awards, further cementing his status as a preeminent figure in the music industry. In April 2024, Hawkins’ contributions were honored with his induction into the International Blues Hall of Fame as a Legendary Blues Artist, a well-deserved recognition of his unique vocal stylings and heartfelt, captivating lyrics that have earned him a devoted global fan base and widespread critical acclaim.

The Indie Music Channel Awards honored independent artists and songwriters for their exceptional achievements, bringing together a diverse array of global talent. Stevie Hawkins stood out in this competitive field, impressing the judges with his exceptional musicality, compelling lyrics, and commanding stage presence.

“I am incredibly grateful to receive these awards,” said Hawkins. “The blues is a powerful form of expression, and to be recognized as the Best Blues Artist and Best Blues Songwriter is truly an honor. I share this moment with my family, fans, and everyone who has supported my music journey.”

Stevie Hawkins & The Blues Messiahs, Hawkins’ band, also won the Best Live Blues Performance accolade at the event, further establishing their reputation as one of the most dynamic acts in the blues genre. Hawkins’ music continues to resonate with fans and newcomers alike, offering a unique blend of vocal artistry and musical prowess. His live performances are a testament to his passion and dedication, drawing enthusiastic crowds wherever he plays.

With a career spanning over four decades, Stevie Hawkins continues to push the boundaries of blues music and inspire listeners with his soulful performances. His latest accolades at the Indie Music Channel Awards are a testament to his enduring talent and unwavering dedication to his craft, and he looks forward to continuing his musical journey and sharing his love for blues with audiences around the world.

For more information about Stevie Hawkins and his music, please visit his website.

Media Contact
Company Name: Stevie Hawkins
Email: Send Email
Phone: (678) 561.3846
Address:9234 Kingston Pike #361
City: Knoxville
State: TN
Country: United States
Website: https://steviehawkins.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: International Blues Hall of Fame Legendary Blues Artist Stevie Hawkins Takes Home Two Blues Music Awards

Refinery Catalysts Market Size, Trends, Opportunities, Key Segmentation, Regional Growth, Leading Companies, and Forecast to 2029

“Browse 250 market data Tables and 50 Figures spread through 212 Pages and in-depth TOC on “Refinery Catalysts Market””
The Refinery Catalysts Market is driven by the need for efficient fuel processing and cleaner emissions. Future growth is fueled by advancements in catalyst technology and increasing demand for high-quality fuels, with significant activity in Asia-Pacific and North America.

The refinery catalysts market is projected to reach USD 6.8 million by 2029, at a CAGR of 4.0% from USD 5.6 million in 2024. The combination of stringent environmental regulations, growing demand for fuels, and technological advancements are driving the refinery catalysts market.

Based on type, the refinery catalysts market has been segmented into FCC catalysts, hydrotreating catalysts, hydrocracking catalysts, catalytic reforming catalysts, and others. Hydrocracking catalyst is the fastest-growing type in the refinery catalysts market. Hydrocracking catalysts aid in converting heavy oil feedstock into lighter petroleum products. Metals catalysts are mostly used in this process due to their catalytic reaction and environmental sustainability properties. The rise in the demand for high quality fuels with low emissions backed by stringent environmental regulations influence the market for hydrocracking catalysts. Adaption of hydrocracking units in the refinery process also increases the operational efficiency and quality of product yield.  

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=84

Based on ingredients, the refinery catalysts industry has been segmented into zeolites, metals, rare earth metals, transition and base metals and chemical compounds. Zeolites is one of the fastest-growing ingredients for refinery catalyst applications due to its efficient capability to work and increasing demand. Zeolite catalysts are used majorly in FCC processes. They have high acid strength and ability to control molecular access to the internal structure. The expanding economies of the Asia Pacific, the Middle East, and Africa provide significant opportunities for refinery catalyst manufacturers, with countries like India, Brazil, and China experiencing rapid growth in industrialization and driving demand for refinery catalysts.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=84 

Asia Pacific is the largest market for refinery catalysts. The oil refinery industry in Asia Pacific benefits greatly from refinery catalysts, as they improve product quality. Additionally, the region’s robust industrial growth, especially in emerging economies like China and India, fuels demand for refinery catalysts in oil refineries. The increase in income spending parity in developing countries like India, China, and Indonesia is influencing the automotive sector in these countries. Automobiles require the use of petroleum based products which are formed through the refining process. The quality of these products depends on the refinery catalysts which are used during the refining process. Thus, the increase in automotive market in the developing countries is directly influencing the growth of refinery catalysts in Asia Pacific.

The key global players in the refinery catalysts market, such as Albemarle Corporation (US), W R Grace (US), BASF (Germany), Haldor Topsoe (Denmark), Honeywell UOP (US), Clariant (Switzerland), Axens (France), Johnson Matthey (UK), China Petroleum and Chemical Corporation (Sinopec) (China), Shell Catalyst & Technologies (Netherlands) and others.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=84 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/refinery-catalyst-advanced-technologies-and-global-market-84.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Refinery Catalysts Market Size, Trends, Opportunities, Key Segmentation, Regional Growth, Leading Companies, and Forecast to 2029

Pro Ads Shop – 7 Years of Excellence in Providing Verified Facebook Profiles, Business Managers, and Pages

“Pro Ads – Buy Facebook Profiles, Verified BMs, Pages”
Pro Ads a leading provider of verified Facebook profiles, business managers, and pages. Since 2017, the company has supported businesses and digital marketers by offering secure, compliant solutions for navigating Facebook’s advertising tools.

ProAds.shop has proudly delivered premium services in the digital advertising space for 7 years. Specializing in verified Facebook profiles, business managers, and pages. Since its inception, Pro Ads has been at the forefront of helping businesses and digital marketers overcome challenges related to Facebook advertising, ensuring smooth and secure access to critical advertising tools.

A Proven Track Record in Supporting Digital Growth

Founded in 2017, Pro Ads has consistently evolved to meet the needs of its diverse client base, ranging from small businesses to large agencies. With a strong commitment to quality and compliance, ProAds.shop has established itself as a trusted partner in the digital advertising community, helping clients navigate the complexities of Facebook’s policies and account restrictions.

Comprehensive Services Built on Seven Years of Expertise

Verified Facebook Profiles: Over the years, Pro Ads has mastered the art of providing verified Facebook profiles that enable clients to bypass the common issues associated with unverified accounts. These profiles come with a strong history of compliance, reducing the risk of suspensions and ensuring a reliable foundation for advertising activities.

Business Managers: Recognizing the need for efficient asset management, ProAds.shop offers verified Business Managers for agencies and businesses handling multiple ad accounts. This service allows for streamlined management and operation, enhancing the ability to scale advertising efforts without interruption.

Facebook Pages: ProAds.shop’s portfolio includes a wide range of verified Facebook Pages that are ready for immediate use. These pages are perfect for businesses looking to launch campaigns swiftly and confidently, leveraging ProAds.shop’s rigorous verification process to ensure compliance and performance.

Why Businesses Choose Pro Ads:

Unmatched Experience: With seven years in the industry, ProAds.shop has built a deep understanding of Facebook’s evolving landscape, enabling it to offer solutions that are both effective and forward-thinking.

Commitment to Compliance: We prioritizes adherence to Facebook’s guidelines, providing clients with verified assets that minimize the risk of disruptions and ensure sustained advertising success.

Customer-Centric Approach: The company’s focus on customer satisfaction and support has garnered a loyal client base, who trust ProAds.shop to deliver on its promises with consistency and integrity.

Reflecting on the company’s journey, Harold, CEO of ProAds.shop, said, “Our success over the past seven years is a testament to our unwavering dedication to providing reliable, verified Facebook assets. We’ve grown alongside our clients, adapting our services to meet their evolving needs, and we’re excited to continue this journey of supporting digital marketers with the best tools available.”

About ProAds.shop

ProAds.shop is a leading provider of verified Facebook profiles, business managers, and pages, with seven years of experience in the digital advertising industry. Known for its commitment to quality and compliance, Pro Ads helps businesses and marketers overcome the challenges of Facebook advertising, enabling them to scale their operations and achieve their goals with confidence.

For more information, visit https://proads.shop/.

Media Contact
Company Name: Pro Ads Digital LLC
Contact Person: Harold Guererro
Email: Send Email
Phone: +1 (317) 961-0407
City: Boulder
State: Colorodo
Country: United States
Website: https://proads.shop/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pro Ads Shop – 7 Years of Excellence in Providing Verified Facebook Profiles, Business Managers, and Pages

Biospecimen Contract Research Services Market Surge: Key Developments and Forecasts

“Biospecimen Contract Research Services Market”
Biospecimen Contract Research Services Market is predicted to record a promising CAGR of 9.3% between 2024 and 2031.

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “ Global Biospecimen Contract Research Services Market (By Biospecimen Types(Oncological Studies, FFPE Tissue, Frozen Tissue, Plasma / Serum, Other Biospecimens, Non-Oncological Studies, Blood Products, Human Tissue, Other Biospecimens), Therapeutic Area(Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas))- Market Outlook and Industry Analysis 2030″

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/1264

According to company’s newest research, the Global Biospecimen Contract Research Services Market is predicted to record a promising CAGR of 9.3% between 2024 and 2031.

A biospecimen is a sample of material taken from humans, animals, or plants and may consist of urine, blood, tissue, cells, DNA, RNA, or protein, among other things. Biospecimens can either be put through an examination in a laboratory or kept in a biorepository for later use in a scientific investigation. Biomedical research is an ever-evolving process that includes a wide range of experiments to study diseases and their therapy options; biospecimens are credited as critical components of this process, beginning with drug development and extending to clinical trials and epidemiological studies inquiries. More than that, biospecimens bridge the gap between a patient’s biological characteristics and the creation of individualised treatment plans in the field of precision medicine. In order to take benefit of more cost-effective procedures and get over the current capacity limits, the pharmaceutical sector is increasingly turning to outsourcing bioanalytical services.

The Biospecimen Contract Research Services Market is growing as a result of rising pharmaceutical R&D spending, an increase in the number of clinical trials, and the expensive cost of developing drugs in-house (encouraging pharma-biotech companies to outsource). Market participants can look forward to a wide range of growth opportunities, including an expanding drugs and biologics market despite the COVID-19 pandemic, growing demand for specialised testing services among end-users, and a requirement for novel clinical trial designs for complex cell and gene therapies. The market expansion will be fueled by service agreements, after which acquisition or merger will take place. Adopting new technologies and methods is hampered by a lack of qualified personnel impedes market expansion.

The market for biospecimen contract research services was led by North America, which had a dominant share worldwide. The rapid growth of this market, the growing emphasis on outsourcing by pharmaceutical and biopharmaceutical companies, and the rise in the number of clinical trial activities in North America are the primary factors that contribute to the region’s dominant position in this industry.

Some of the primary key players in the Biospecimen Contract Research Services market are BioChain Institute, BioIVT, Boca Biolistics, Creative Bioarray, Cureline, Discovery Life Sciences, Infinity BiologiX, Precision for Medicine, Inc., PrecisionMed, Inc., Medicover, National BioService, ICON plc, The MT Group, Eolas Biosciences Co. Ltd, Indivumed GmbH, Ardent Clinical Research Services, Capital Biosciences, Inc., GR BioResearch, REPROCELL, Trans-Hit Bio (Azenta US, Inc.) and iSpecimen.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Key Developments in the market

  • In May 2022, Discovery Life SciencesTM announced that they had acquired the Gentest® business unit from the Life Sciences division of Corning Incorporated. The merging of Discovery’s companies increases the company’s ability to provide scientifically-based biospecimen medication and biomarker development capabilities. As a direct consequence of this, customers are able to negotiate the complex terrain of their drug development programmes in a manner that is both more time and money efficient as a result of a one-of-a-kind innovation engine.
  • In Apr 2022, A commercial blood bank known as BioIVT recently completed the acquisition of Tennessee Blood Services. As a result of the deal, BioIVT’s donor base is expanded, and the company’s capacity to offer fresh whole blood, plasma, serum, and red blood cells for the development of pharmaceuticals and diagnostics is increased.
  • In Oct 2021, Azenta Life Sciences and Cleveland Clinic launched a new 22,000-square-foot facility for the handling and storage of biospecimen samples on the main campus of Cleveland Clinic. The two-story biorepository, which features ultra-cold and cryogenic storage for the Cleveland Clinic and other institutions, is operated by Brooks’ freshly rebranded life sciences branch, Azenta Life Sciences. The new building will expand the Cleveland Clinic’s biobanking capabilities and accelerate translational research.
  • In Mar 2021, Scientist.com and Cureline formed a partnership to improve researchers’ access to human biospecimens and make the process more efficient. Because of the direct connection that had been made between the marketplace on Scientist.com and the new online webstore that Cureline had launched, consumers now had access to a wide variety of certified human biospecimens almost immediately.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/1264

Market Segmentation

Global Biospecimen Contract Research Services Market, by Biospecimen Types, 2022-2030 (Value US$ Mn)

  • Oncological Studies
  • FFPE Tissue
  • Frozen Tissue
  • Plasma / Serum
  • Other Biospecimens
  • Non-Oncological Studies
  • Blood Products
  • Human Tissue
  • Other Biospecimens

Global Biospecimen Contract Research Services Market, by Therapeutic Area, 2022-2030 (Value US$ Mn)

  • Oncological Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Other Therapeutic Areas

Global Biospecimen Contract Research Services Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Biospecimen Contract Research Services Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Biospecimen Contract Research Services Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Biospecimen Contract Research Services Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Biospecimen Contract Research Services Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Biospecimen Contract Research Services Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for the global Global Biospecimen Contract Research Services Market
  • To receive an industry overview and future trends of the Biospecimen Contract Research Services Market
  • To analyze the Global Biospecimen Contract Research Services Market drivers and challenges
  • To get information on the Global Biospecimen Contract Research Services Market size (Value US$ Mn) forecast to 2030
  • Significant investments, mergers & acquisitions in the Global Biospecimen Contract Research Services Market industry

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1264                                                                                                                                  

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biospecimen Contract Research Services Market Surge: Key Developments and Forecasts

Centesis Catheters Market Set to Soar as Healthcare Technologies Advance

“Centesis Catheters Market”
Centesis Catheters market is estimated to reach over USD 860.68 million by 2031, exhibiting a CAGR of 5.74% during the forecast period.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Centesis Catheters Market Size, Share & Trends Analysis Report By Type (Small-Bore Centesis Catheters and Large-Bore Centesis Catheters), By Procedure (Paracentesis, Thoracentesis, Arthrocentesis, and Amniocentesis), By Application (Diagnostic, Therapeutic, and Palliative Care), By End-User (Hospitals, Ambulatory Surgical Centers)- Market Outlook And Industry Analysis 2031”

The global Centesis Catheters market is estimated to reach over USD 860.68 million by 2031, exhibiting a CAGR of 5.74% during the forecast period. 

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/1696

Centesis Catheters are produced using plant or animal waste and are environmentally friendly, non-toxic and abundant in nature. Due to growing concerns over the rapid depletion of oil and gas reserves, the adoption of Centesis Catheters is expected to increase in the next coming years. Fluctuations in crude oil prices and rising green chemistry applications in various industries are among the other factors expected to boost the growth of the global Centesis Catheters market. Moreover, shifting consumer preference towards green and sustainable products, coupled with growing urbanization, and high disposable income, are factors expected to create potential revenue opportunities for players operating in the global Centesis Catheters market. Increased investments by major players and new advancements for the development of various end-use products have created lucrative revenue opportunities for major manufacturers and suppliers of the Centesis Catheters. Favorable government initiatives to promote the use of Centesis Catheters owing to vehicle emissions and other environmental concerns are expected to support the growth of the target market. Government initiatives such as “Made in India” and “Made in China” encourage many small players to enter the market, thereby driving the market demand for Centesis Catheters and ultimately increasing competition, boosting market growth.

List of Prominent Players in the Centesis Catheters Market:

  • AngioDynamics, Inc. (US)
  • ARGON MEDICAL
  • Avanos Medical Devices (US)
  • Axiom Medical, Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • BD
  • Blue Neem Medical Devices Pvt. Ltd. (India)
  • Boston Scientific Corporation
  • Braun SE
  • Canadian Hospital Specialties Ltd. (Canada)
  • Cardinal Health (US)
  • Cook Medical (US)
  • Galt Medical Corp. (US)
  • Guangzhou Leadgem Medical Device Co., Ltd. (China)
  • KM Medical (US)
  • Medical Components, Inc. (US)
  • Medtronic (Ireland)
  • Merit Medical Systems (US)
  • Mermaid Medical A/S (Denmark)
  • PFM Medical, Inc.
  • Redax S.P.A.
  • Rocket Medical Plc
  • Teleflex Incorporated
  • UreSil, LLC.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:

Drivers-

Growing demand for bioethanol as an alternative fuel in the automotive industry owing to its properties such as reduced carbon dioxide emissions, cost-efficiency, etc., is a key aspect expected to drive the growth of the target market. Increasing demand for Centesis Catheters in the production of intermediate chemical products is another factor expected to contribute significant revenue share in the global Centesis Catheters market. Additionally, the rising demand for Centesis Catheters in packaging materials due to its properties, such as easy disposal, low production cost, and others, is a factor expected to augment the growth of the global Centesis Catheters market.

Challenges:

The prime challenge is the lack of awareness and commercialization regarding bio-based products in developing countries, which is predicted to reduce the growth of the Centesis Catheters market. However, the high cost of Centesis Catheters and the availability of synthetic chemicals are factors expected to hamper the overall development of the Centesis Catheters market over the coming years. Owing to the COVID-19 outbreak, the number of cases has been increasing, which led to a global or partial shutdown to maintain social distancing. According to a recent update, the industries are facing unprecedented economic losses due to disruptions in global supply chains for key players operating in the global Centesis Catheters market. Distributors, suppliers and retailers have inventory but can’t sell, and manufacturers have to stop production from dealing with the shutdown.

Regional Trends:

In the near future, the North American Centesis Catheters market is anticipated to account for a sizable revenue share and to expand at a rapid rate. The growth of the Centesis Catheters market in the region is anticipated to be propelled by factors such as a growing population, accelerated urbanization, rising industrialization, and rising R&D expenditures by key players. In addition, Europe held a considerable share of the market due to its developed economy and growing product adoption. This is due to the prominent participants in the Centesis Catheters market adopting new strategies. In addition, the global Centesis Catheters market has the potential to expand due to the presence of key market players and the increasing collaboration among major players for market penetration in the region.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1696

Recent Developments:

  • In June 2021, JSW Cement Limited entered the construction chemicals sector with a new range of green products that consume less water during usage. It replaces the use of river sand in the concrete pouring process with screening residues, thereby protecting natural resources and helping to prevent landslides, floods and air pollution.

Segmentation of Centesis Catheters Market-

By Type-

  • Small-Bore Centesis Catheters
  • Large-Bore Centesis Catheters

By Procedure-

  • Paracentesis
  • Thoracentesis
  • Arthrocentesis
  • Amniocentesis
  • Other Centesis Procedures

By Application-

  • Diagnostic Applications
  • Therapeutic Applications
  • Palliative Care Applications

By End-Use-

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Use

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1696

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Centesis Catheters Market Set to Soar as Healthcare Technologies Advance